Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Deepcell Scores $73M Series B

2022-03-19
MENLO PARK, CA, Deepcell, a life science company, has closed its $73 million Series B round of financing led by Koch Disruptive Technologies.
Deepcell, a life science company pioneering AI-powered single cell classification and isolation for basic and translational research, has closed its $73 million Series B round of financing.

This round of funding was led by Koch Disruptive Technologies and joined by new investors including Bridger Healthcare, Horizons Ventures, Casdin Capital and lead investors from previous rounds, Andreessen Horowitz and Bow Capital as well as Jeff Dean, Head of Google Brain, and Matt Mcllwain, Managing Director at Madrona Venture Group.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors